144 related articles for article (PubMed ID: 34416061)
1. Patient preferences for curettage followed by imiquimod 5% cream vs. surgical excision for the treatment of non-facial nodular basal cell carcinoma: a discrete choice experiment.
Sinx KAE; Mosterd K; de Coster D; Essers BA
J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):e41-e43. PubMed ID: 34416061
[No Abstract] [Full Text] [Related]
2. What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trial.
Tinelli M; Ozolins M; Bath-Hextall F; Williams HC
BMC Dermatol; 2012 Oct; 12():19. PubMed ID: 23035730
[TBL] [Abstract][Full Text] [Related]
3. Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage.
Neville JA; Williford PM; Jorizzo JL
J Drugs Dermatol; 2007 Sep; 6(9):910-4. PubMed ID: 17941362
[TBL] [Abstract][Full Text] [Related]
4. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial.
Bath-Hextall F; Ozolins M; Armstrong SJ; Colver GB; Perkins W; Miller PS; Williams HC;
Lancet Oncol; 2014 Jan; 15(1):96-105. PubMed ID: 24332516
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of treatment of superficial basal cell carcinoma: surgical excision vs. imiquimod 5% cream.
Vanaclocha F; Daudén E; Badía X; Guillén C; Conejo-Mir JS; Sainz de Los Terreros M; Hamel L; Llorens MA;
Br J Dermatol; 2007 Apr; 156(4):769-71. PubMed ID: 17263811
[No Abstract] [Full Text] [Related]
6. Successful treatment of basal cell carcinoma on the face with imiquimod 5% cream.
Oster-Schmidt C; Altmeyer P; Stücker M
Acta Derm Venereol; 2002; 82(6):477. PubMed ID: 12575864
[No Abstract] [Full Text] [Related]
7. To the editor: incompletely excised basal cell carcinoma treated with 5% imiquimod cream.
Rivera A; Markus J; Pielop JA; Orengo I
Dermatol Surg; 2005 Nov; 31(11 Pt 1):1481-2. PubMed ID: 16416627
[No Abstract] [Full Text] [Related]
8. Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma.
Shulstad RM
Dermatol Nurs; 2009; 21(2):86-7. PubMed ID: 19507375
[TBL] [Abstract][Full Text] [Related]
9. 5% imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma.
Torres A; Niemeyer A; Berkes B; Marra D; Schanbacher C; González S; Owens M; Morgan B
Dermatol Surg; 2004 Dec; 30(12 Pt 1):1462-9. PubMed ID: 15606733
[TBL] [Abstract][Full Text] [Related]
10. Imiquimod 5% cream following curettage without electrodesiccation for basal cell carcinoma: preliminary report.
Rigel DS; Torres AM; Ely H
J Drugs Dermatol; 2008 Jan; 7(1 Suppl 1):s15-6. PubMed ID: 18277458
[TBL] [Abstract][Full Text] [Related]
11. Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial.
Williams HC; Bath-Hextall F; Ozolins M; Armstrong SJ; Colver GB; Perkins W; Miller PSJ;
J Invest Dermatol; 2017 Mar; 137(3):614-619. PubMed ID: 27932240
[TBL] [Abstract][Full Text] [Related]
12. The SINS trial: a randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma.
Ozolins M; Williams HC; Armstrong SJ; Bath-Hextall FJ
Trials; 2010 Apr; 11():42. PubMed ID: 20409337
[TBL] [Abstract][Full Text] [Related]
13. Comment on "Surgery versus combined treatment with curettage and imiquimod for nodular basal cell carcinoma: One-year results of a noninferiority, randomized, controlled trial".
Pitney T; Muir J
J Am Acad Dermatol; 2021 Jan; 84(1):e55. PubMed ID: 32860912
[No Abstract] [Full Text] [Related]
14. Reply to: Comment on "Surgery versus combined treatment with curettage and imiquimod for nodular basal cell carcinoma: One-year results of a noninferiority, randomized, controlled trial".
Sinx K; Mosterd K
J Am Acad Dermatol; 2021 Jan; 84(1):e57. PubMed ID: 32861711
[No Abstract] [Full Text] [Related]
15. An open-label, pilot study examining the efficacy of curettage followed by imiquimod 5% cream for the treatment of primary nodular basal cell carcinoma.
Wu JK; Oh C; Strutton G; Siller G
Australas J Dermatol; 2006 Feb; 47(1):46-8. PubMed ID: 16405483
[TBL] [Abstract][Full Text] [Related]
16. Facial extensive recurrent basal cell carcinoma: successful treatment with photodynamic therapy and imiquimod 5% cream.
Requena C; Messeguer F; Llombart B; Serra-Guillén C; Guillén C
Int J Dermatol; 2012 Apr; 51(4):451-4. PubMed ID: 22435437
[TBL] [Abstract][Full Text] [Related]
17. Resolution of tinea pedis with imiquimod cream 5% in a patient with nodular basal cell carcinoma.
Stashower ME
Cutis; 2006 Jul; 78(1):66-9. PubMed ID: 16903324
[TBL] [Abstract][Full Text] [Related]
18. Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion.
Sterry W; Ruzicka T; Herrera E; Takwale A; Bichel J; Andres K; Ding L; Thissen MR
Br J Dermatol; 2002 Dec; 147(6):1227-36. PubMed ID: 12452875
[TBL] [Abstract][Full Text] [Related]
19. 5% imiquimod cream for the treatment of large superficial basal cell carcinoma.
Shumack S; Gebauer K; Quirk C; Macdonald K; Walters SA; Owens M
Arch Dermatol; 2004 Oct; 140(10):1286-7. PubMed ID: 15492202
[No Abstract] [Full Text] [Related]
20. Definitive surgical treatment of 24 skin cancers not cured by prior imiquimod therapy: a case series.
Murphy ME; Brodland DG; Zitelli JA
Dermatol Surg; 2008 Sep; 34(9):1258-63. PubMed ID: 18554288
[No Abstract] [Full Text] [Related]
[Next] [New Search]
